MedPath
TGA Approval

LIBTAYO cemiplimab 350 mg concentrate for solution for infusion (320609)

320609

LIBTAYO cemiplimab 350 mg concentrate for solution for infusion

Medison Pharma Australia Pty Ltd

July 17, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ea10a544998ea10d30103bb18061ab07.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/7e459e71b0f4a2f932a8fde098ca1082.pdf

Active Ingredients

cemiplimab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.